Expand chart
Data: Money.net; Chart: Axios Visuals

Worldwide sales of Humira, AbbVie's heavily advertised prescription drug that treats rheumatoid arthritis and other ailments, hit $18.4 billion in 2017 — an increase of more than 14%. Humira represented about two-thirds of AbbVie's total revenue.

The big picture: Humira, which costs $38,000 after rebates, is the top-selling drug on the planet. If Humira were a standalone company, it would be larger than many Fortune 500 conglomerates, such as General Mills, Halliburton or Xerox.

Go deeper

Updated 16 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Politics: The swing states where the pandemic is raging. Ex-FDA chief: Pence campaigning after COVID exposure puts others at risk — Mark Meadows: "We are not going to control the pandemic"
  2. Health: 13 states set single-day coronavirus case records last week — U.S. reports over 80,000 new cases for second consecutive day.
  3. Education: The dangerous instability of school re-openings.
  4. World: Australian city to exit one of world's longest lockdowns — In photos: Coronavirus restrictions grow across Europe
  5. Media: Fox News president and several hosts advised to quarantine after possible COVID-19 exposure
  6. Nonprofit: Rockefeller Foundation commits $1 billion for COVID-19 recovery
Erica Pandey, author of @Work
58 mins ago - Economy & Business

The dangerous instability of school re-openings

Illustration: Eniola Odetunde/Axios

Schools across the country have flip-flopped between in-person and remote learning — and that instability is taking a toll on students' ability to learn and their mental health.

The big picture: While companies were able to set long timelines for their return, schools — under immense political and social strain — had to rush to figure out how to reopen. The cobbled-together approach has hurt students, parents and teachers alike.

Dan Primack, author of Pro Rata
1 hour ago - Politics & Policy

Trump doesn't have a second-term economic plan

Illustration: Aïda Amer/Axios

President Trump has not laid out an economic agenda for his second term, despite the election being just eight days away.

Why it matters: This is unprecedented in modern presidential campaigns, and makes it harder for undecided voters to make an informed choice.